8 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Risk Factors For Active ... Active: Symptomatic ... Active TB: • ... : Active TB: • ... #ActiveTB #LatentTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Risk Factors For Active ... Active: Symptomatic ... Active TB: • ... : Active TB: • ... #ActiveTB #LatentTB
Notice the cavitation especially on the right.
In the left upper lobe there is probably some traction-bronchiectasis
the left upper lobe ... #Clinical #Radiology ... #Pulmonary #CTChest ... Tuberculosis #TB #Active ... TractionBronchiectasis #RadiologyAssistant
On the left some diseases with a nodular pattern.
1. Hypersensitivity pneumonitis: ill defined centrilobular nodules.
2. Miliary
diseases with a nodular ... a patient with active ... #Clinical #Diagnosis ... #Radiology #Pulmonary ... Comparison #Table #RadiologyAssistant
TB
This patient presented first with the CXR on the left.
The findings are:
Widespread ill-defined densities, which are
the right upper lobe ... reactivation of a latent ... #Clinical #Radiology ... Tuberculosis #TB #Active ... SecondaryTB #Cavitary #RadiologyAssistant
Primairy TB is usually clinically silent.
In 5% of infected individuals the immunity is inadequate and clinically
TB is usually clinically ... active disease ... reactivation of the latent ... the left upper lobe ... #SecondaryTB #RadiologyAssistant
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
noncompliance • Clinical ... initiation Clinical ... Lymphadenitis, pulmonary ... lymphadenitis, pulmonary ... • Persistently active
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
gland) biopsy • Ocular ... salivary ducts Clinical ... , INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... muscarinic agonists • Active